Figure 1
From: Dynamics of inflammation resolution and symptom recovery during AECOPD treatment
Resolution of airway inflammatory biomarkers including myeloperoxidase (MPO, A), neutrophils (B) and interleukin (IL)-8 (C) during the treatment of AECOPD (day 0, 4, 7 and 14) and in the subsequent baseline (8 w).
